186 related articles for article (PubMed ID: 21892339)
1. Estradiol valerate and dienogest: a new approach to oral contraception.
Kiley JW; Shulman LP
Int J Womens Health; 2011; 3():281-6. PubMed ID: 21892339
[TBL] [Abstract][Full Text] [Related]
2. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.
Rafie S; Borgelt L; Koepf ER; Temple-Cooper ME; Lehman KJ
Int J Womens Health; 2013; 5():313-21. PubMed ID: 23788843
[TBL] [Abstract][Full Text] [Related]
3. Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill.
Guida M; Bifulco G; Di Spiezio Sardo A; Scala M; Fernandez LM; Nappi C
Int J Womens Health; 2010 Aug; 2():279-90. PubMed ID: 21151673
[TBL] [Abstract][Full Text] [Related]
4. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
[TBL] [Abstract][Full Text] [Related]
5. Estradiol valerate/dienogest: a novel oral contraceptive.
Whalen KL; Rose R
Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
[TBL] [Abstract][Full Text] [Related]
6. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
7. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.
Nappi RE; Serrani M; Jensen JT
Int J Womens Health; 2014; 6():711-8. PubMed ID: 25120376
[TBL] [Abstract][Full Text] [Related]
8. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
9. Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
Micks E; Jensen JT
Womens Health (Lond); 2011 Sep; 7(5):513-24. PubMed ID: 21879819
[TBL] [Abstract][Full Text] [Related]
10. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
Micks EA; Jensen JT
Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
[TBL] [Abstract][Full Text] [Related]
11. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
12. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Nappi RE
Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
[TBL] [Abstract][Full Text] [Related]
14. Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.
Briggs P; Serrani M; Vogtländer K; Parke S
Int J Womens Health; 2016; 8():477-487. PubMed ID: 27695365
[TBL] [Abstract][Full Text] [Related]
15. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
17. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
Graziottin A
Minerva Ginecol; 2014 Oct; 66(5):479-95. PubMed ID: 25245997
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
[TBL] [Abstract][Full Text] [Related]
19. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
[TBL] [Abstract][Full Text] [Related]
20. Contraception with estradiol valerate and dienogest: adherence to the method.
Fruzzetti F; Paoletti AM; Fidecicchi T; Posar G; Giannini R; Gambacciani M
Open Access J Contracept; 2019; 10():1-6. PubMed ID: 31191048
[No Abstract] [Full Text] [Related]
[Next] [New Search]